Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Net Income towards Common Stockholders of $0.12 for Q1 2026, up 11.3% year-over-year from $0.11 in Q1 2025, and down 100.0% quarter-over-quarter from $55.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Net Income towards Common Stockholders for 7 consecutive years, with $0.12 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 11.3% year-over-year to $0.12; the TTM figure through Mar 2026 stood at $55.4 million (up 7.22% YoY), while the FY2025 annual figure was $162.8 million, up 29.34% from the prior year.
- Net Income towards Common Stockholders retreated to $0.12 in Q1 2026 per STVN's latest filing, from $55.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $55.4 million in Q4 2025 and bottomed at $0.08 in Q1 2024.
- Historically, Net Income towards Common Stockholders has averaged $18.0 million across 5 years, with a median of $0.15 in 2025.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders soared 65.99% — and 2023, when it tumbled 100.0%.
- Stevanato Group S.p.A's Net Income towards Common Stockholders stood at $49.4 million in 2022, then retreated by 1.41% to $48.7 million in 2023, then increased by 6.08% to $51.6 million in 2024, then grew by 7.22% to $55.4 million in 2025, then tumbled by 100.0% to $0.12 in 2026.
- Business Quant data shows STVN's Net Income towards Common Stockholders at $0.12 in Q1 2026, $55.4 million in Q4 2025, and $0.15 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 55.36 Mn |
| Sep 30, 2025 | 0.15 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 51.63 Mn |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 48.67 Mn |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 36.51 Mn |
| Jun 30, 2022 | 32.58 Mn |
| Mar 31, 2022 | 31.11 Mn |
| Dec 31, 2021 | 51.11 Mn |
| Sep 30, 2021 | 22.00 Mn |